MEDIAN Technologies S.A. announced that it has appointed Dr. Kapil Dhingra director for a three-year term. He founded KAPital Consulting LLC to advise pharmaceutical Anns on oncology research.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.6 EUR | -3.35% |
|
-0.38% | -45.26% |
May. 22 | Median: service contract with a major pharmaceutical company | CF |
May. 21 | Median Technologies Becomes Preferred Vendor to Another Top 3 Pharmaceutical Company | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-45.26% | 53.49M | |
+1.15% | 203B | |
+4.69% | 178B | |
+31.83% | 157B | |
+33.39% | 112B | |
+2.21% | 64.58B | |
+22.99% | 56.33B | |
-4.03% | 46.75B | |
-8.60% | 36.59B | |
+2.35% | 35.09B |
- Stock Market
- Equities
- ALMDT Stock
- News Median Technologies
- MEDIAN Technologies S.A. Appoints Kapil Dhingra as Director